Group B streptococcus type II antisera have anti-galactan specificities

Area of Science:

• Immunochemistry
• Microbiology
• Glycobiology

Background:

• Group B Streptococcus (GBS) is a significant human pathogen.
• Capsular polysaccharides (CPS) are key virulence factors and serotype determinants in GBS.
• Type II GBS CPS possesses unique structural features influencing host-pathogen interactions.

Purpose of the Study:

• To characterize the immunodominant structures of type II GBS CPS.
• To explore the potential of using anti-galactan reagents for GBS type II identification.
• To investigate the cross-reactivity between GBS CPS and various galactan-binding proteins.

Main Methods:

• Immunochemical analysis of type II GBS capsular polysaccharides.
• Detection of terminal non-reducing beta-(1-6)-D-galactosyl groups using specific antisera.
• Testing the reactivity of anti-type II GBS antisera with plant and animal galactans.
• Evaluating the binding of various anti-galactans (lectins, myeloma proteins) to different GBS types.

Main Results:

• Type II GBS CPS was confirmed to possess terminal non-reducing beta-(1-6)-D-galactosyl groups.
• Rabbit immune antisera against type II GBS specifically detected this immunodominant structure.
• Anti-type II GBS antisera demonstrated cross-reactivity with various plant and animal galactans.
• Specific lectins and myeloma proteins were found to recognize type II GBS strains and other GBS types.

Conclusions:

• The beta-(1-6)-D-galactosyl structure is a defining feature of type II GBS CPS.
• Anti-galactan antibodies and lectins can serve as valuable tools for identifying GBS type II strains.
• This cross-reactivity highlights shared epitopes between bacterial polysaccharides and host/environmental galactans.